UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neoadjuvant endocrine therapy with or without palbociclib in low-risk patients: a phase III randomized double-blind SAFIA trial

Journal of cancer research and clinical oncology, 2023-08, Vol.149 (9), p.6171-6179

2023

Volltextzugriff (PDF)

Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized Trial

Journal of clinical oncology, 2000-11, Vol.18 (22), p.3758-3767

2000

Volltextzugriff (PDF)

A multicentre, international neoadjuvant, double-blind, randomized phase III trial comparing fulvestrant to a combination of fulvestrant and palbociclib (CDK 4/6 inhibitor) in patients with operable luminal breast cancer responding to fulvestrant (SAFIA study)

Annals of oncology, 2018-10, Vol.29, p.viii85-viii85

2018

Volltextzugriff (PDF)

A longitudinal prospective study of health-related quality of life in breast cancer patients following high-dose chemotherapy with autologous blood stem cell transplantation

Bone marrow transplantation (Basingstoke), 2005-08, Vol.36 (3), p.251-259

2005

Volltextzugriff (PDF)

Anastrozole (Arimidex™) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results

European journal of cancer (1990), 2003-08, Vol.39 (12), p.1684-1689

2003

Volltextzugriff (PDF)

Efficacy of tamoxifen following anastrozole (‘Arimidex’) compared with anastrozole following tamoxifen as first-line treatment for advanced breast cancer in postmenopausal women

European journal of cancer (1990), 2003-11, Vol.39 (16), p.2310-2317

2003

Volltextzugriff (PDF)

Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy

Journal of clinical oncology, 1999-05, Vol.17 (5), p.1413-1424

1999

Volltextzugriff (PDF)

Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer

Journal of clinical oncology, 1996-06, Vol.14 (6), p.1858-1867

1996

Volltextzugriff (PDF)

Phase II Study of Docetaxel, Doxorubicin, and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer

Journal of clinical oncology, 2001-01, Vol.19 (2), p.314-321

2001

Volltextzugriff (PDF)

Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial

The lancet oncology, 2006-08, Vol.7 (8), p.633-643

2006

Volltextzugriff (PDF)

Mastectomy with immediate breast reconstruction after neoadjuvant chemotherapy and radiation therapy. A new option for patients with operable invasive breast cancer. Results of a 20 years single institution study

European journal of surgical oncology, 2011-10, Vol.37 (10), p.864-870

2011

Volltextzugriff (PDF)

Growth Factors and Cytokines Upregulate Gelatinase Expression in Bone Marrow CD34+ Cells and Their Transmigration Through Reconstituted Basement Membrane

Blood, 1999-05, Vol.93 (10), p.3379-3390

1999

Volltextzugriff (PDF)

Advanced breast cancer updates on anastrozole versus tamoxifen

Journal of steroid biochemistry and molecular biology, 2003-09, Vol.86 (3), p.321-325

Nabholtz, J.M

2003

Volltextzugriff (PDF)

Open-label randomised phase III trial of vinflunine versus an alkylating agent in patients with heavily pretreated metastatic breast cancer

Annals of oncology, 2018-04, Vol.29 (4), p.881-887

2018

Volltextzugriff (PDF)

Aromatase inhibitors in the management of early breast cancer

European journal of surgical oncology, 2008-11, Vol.34 (11), p.1199-1207

Nabholtz, J.M

2008

Volltextzugriff (PDF)

Myasthenia gravis in association with allogeneic bone marrow transplantation : clinical observations, therapeutic implications and review of literature

Bone marrow transplantation (Basingstoke), 1997-05, Vol.19 (9), p.939-942

1997

Volltextzugriff (PDF)

Late lines of treatment benefit survival in metastatic breast cancer in current practice?

Breast (Edinburgh), 2011-12, Vol.20 (6), p.574-578

2011

Volltextzugriff (PDF)

Ocular toxicity and cancer chemotherapy: A review

Cancer, 1996-10, Vol.78 (7), p.1359-1373

1996

Volltextzugriff (PDF)

Docetaxel (Taxotere) plus doxorubicin-based combinations: the evidence of activity in breast cancer

Seminars in oncology, 1999-06, Vol.26 (3 Suppl 9), p.7

Nabholtz, J M

1999

Volltextzugriff (PDF)

Prognostic Value of Initial Tumor Parameters After Metastatic Relapse

Cancer investigation, 2011-11, Vol.29 (9), p.635-643

2011

Volltextzugriff (PDF)

Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant

Cancer Immunology Immunotherapy, 1993-07, Vol.36 (4), p.215-222

1993

Volltextzugriff (PDF)

The role of taxanes in the management of breast cancer

Seminars in oncology, 1999-06, Vol.26 (3 Suppl 8), p.1-3

Nabholtz, J M

1999

Volltextzugriff (PDF)

Phase III studies of single-agent docetaxel in patients with metastatic breast cancer who have progressed despite previous chemotherapy regimens: preliminary results

Seminars in oncology, 1998-12, Vol.25 (6 Suppl 13), p.4

1998

Volltextzugriff (PDF)

Use of PEG-rHuMGDF in platelet engraftment after autologous stem cell transplantation

Bone marrow transplantation (Basingstoke), 2000-11, Vol.26 (10), p.1083-1088

2000

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(93)

Publikationsform

Artikel
(130)

Sprache

Englisch
(116)
Französisch
(14)

Erscheinungsjahr

n.n

Thema

Humans
(72)
Female
(58)
Life Sciences & Biomedicine
(56)
Science & Technology
(56)
Oncology
(48)
Breast Neoplasms - Drug Therapy
(43)
Middle Aged
(35)
Biological And Medical Sciences
(33)
Adult
(31)
Aged
(31)
Medical Sciences
(31)
Breast Neoplasms - Pathology
(26)
Chemotherapy
(26)
Breast Cancer
(22)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(20)
Pharmacology. Drug Treatments
(20)
Neoplasm Metastasis
(19)
Antineoplastic Agents
(18)
Treatment Outcome
(17)
Taxoids
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact

Neoadjuvant endocrine therapy with or without palbociclib in low-risk patients: a phase III randomized double-blind SAFIA trial

Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized Trial

A multicentre, international neoadjuvant, double-blind, randomized phase III trial comparing fulvestrant to a combination of fulvestrant and palbociclib (CDK 4/6 inhibitor) in patients with operable luminal breast cancer responding to fulvestrant (SAFIA study)

A longitudinal prospective study of health-related quality of life in breast cancer patients following high-dose chemotherapy with autologous blood stem cell transplantation

Anastrozole (Arimidex™) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results

Efficacy of tamoxifen following anastrozole (‘Arimidex’) compared with anastrozole following tamoxifen as first-line treatment for advanced breast cancer in postmenopausal women

Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy

Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer

Phase II Study of Docetaxel, Doxorubicin, and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer

Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial

Mastectomy with immediate breast reconstruction after neoadjuvant chemotherapy and radiation therapy. A new option for patients with operable invasive breast cancer. Results of a 20 years single institution study

Growth Factors and Cytokines Upregulate Gelatinase Expression in Bone Marrow CD34+ Cells and Their Transmigration Through Reconstituted Basement Membrane

Advanced breast cancer updates on anastrozole versus tamoxifen

Open-label randomised phase III trial of vinflunine versus an alkylating agent in patients with heavily pretreated metastatic breast cancer

Aromatase inhibitors in the management of early breast cancer

Myasthenia gravis in association with allogeneic bone marrow transplantation : clinical observations, therapeutic implications and review of literature

Late lines of treatment benefit survival in metastatic breast cancer in current practice?

Ocular toxicity and cancer chemotherapy: A review

Docetaxel (Taxotere) plus doxorubicin-based combinations: the evidence of activity in breast cancer

Prognostic Value of Initial Tumor Parameters After Metastatic Relapse

Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant

The role of taxanes in the management of breast cancer

Phase III studies of single-agent docetaxel in patients with metastatic breast cancer who have progressed despite previous chemotherapy regimens: preliminary results

Use of PEG-rHuMGDF in platelet engraftment after autologous stem cell transplantation

Suchergebnisse filtern